InsidersTradesSigma
Follow the 에스디바이오센서 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has recorded 12 reports. Market capitalisation: €716.5bn. The latest transaction was disclosed on 24 March 2026 (Purchase). Among the most active insiders: 조영식. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Cotizada en el mercado XKRX, 에스디바이오센서 es una empresa enfocada en el sector de la salud y farmacéutico. Se especializa en el desarrollo de soluciones de diagnóstico y monitoreo de la salud.